These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Development of a rat model of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Marino KL, Zakhary I, Abdelsayed RA, Carter JA, O'Neill JC, Khashaba RM, Elsalanty M, Stevens MR, Borke JL. J Oral Implantol; 2012 Sep; 38 Spec No():511-8. PubMed ID: 21905888 [Abstract] [Full Text] [Related]
31. Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats. Maahs MP, Azambuja AA, Campos MM, Salum FG, Cherubini K. Head Neck; 2011 Feb; 33(2):199-207. PubMed ID: 20848442 [Abstract] [Full Text] [Related]
32. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant? Junquera L, Gallego L. J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043 [No Abstract] [Full Text] [Related]
35. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones. Li YF, Hu J. Int J Oral Maxillofac Surg; 2013 Jan; 42(1):149-50. PubMed ID: 22763138 [No Abstract] [Full Text] [Related]
37. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? Brown JJ, Ramalingam L, Zacharin MR. Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397 [Abstract] [Full Text] [Related]
38. Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case. Frei M, Bornstein MM, Schaller B, Reichart PA, Weimann R, Iizuka T. J Oral Maxillofac Surg; 2010 Apr; 68(4):863-7. PubMed ID: 20307770 [No Abstract] [Full Text] [Related]
40. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases. Lee JJ, Cheng SJ, Wang YP, Jeng JH, Chiang CP, Kok SH. Head Neck; 2013 Jan; 35(1):E6-10. PubMed ID: 21523843 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]